癌症中的IRAK信号:机制,向和临床影响
Eric J Vick1,2,3, Daniel T Starczynowski2,3,4,5
1Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH, USA.
Expert opinion on investigational drugs
|October 10, 2025
概括
介素-1受体相关激酶 (IRAKs) 在癌症中至关重要. 针对IRAKs的抑制剂显示出治疗各种癌症的前景,目前正在进行的研究重点是优化治疗和患者选择.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 介素-1受体相关激酶 (IRAKs) 是先天免疫和炎症中的关键信号分子.
- 失调的IRAK信号与癌症的发病,进展和对治疗的抵抗有关.
- 虽然IRAK的研究主要集中在血液性恶性瘤上,但新出现的证据强调了它们在固体瘤中的作用.
研究的目的:
- 审查目前对癌症IRAK生物学的理解.
- 专注于针对IRAKs的治疗策略.
- 讨论 IRAK 向疗法的转化潜力.
主要方法:
- 在癌症中IRAK信号的文献综述.
- 对当前和临床前IRAK抑制剂开发的分析.
- 检查治疗策略和生物标志物研究.
主要成果:
- 除了炎症功能之外,IRAKs在各种癌症中发挥着重要作用.
- 几种IRAK抑制剂正在临床试验或临床前开发中.
- 在血液和固体瘤中,IRAKs具有治疗意义.
结论:
- IRAK 抑制剂和降解剂代表了有前途的癌症治疗方法.
- 优化激酶选择性和识别生物标志物对于临床成功至关重要.
- 向IRAKs为癌症治疗提供了显著的翻译潜力.
相关概念视频
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K


